Intranasal Prime-Boost RNA Vaccination Elicits Potent T Cell Response for Lung Cancer Therapy

Researchers developed a non-invasive intranasal cancer vaccine utilizing circular RNA encapsulated in lipid nanoparticles to induce localized mucosal immune responses.